Active ingredientBevemipretideCat. No. P-B070-001CAS 2356106-71-1Family · Pharmaceutical analytical standards
Bevemipretide
A second-generation investigational peptidomimetic that accumulates in mitochondria and stabilises cardiolipin in their inner membrane; successor to elamipretide, it entered human studies in 2020 for neurodegenerative diseases such as ALS. This family brings together the active ingredient.
Did you know?Compared with its predecessor it reaches higher levels in the brain and can be taken by mouth; in its name, the suffix -tide marks peptides and '-pretide' links it to elamipretide.
Go to the active ingredient →Active ingredientBevemipretideCat. No. P-B070-001CAS 2356106-71-1No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.